NCT01507155View on ClinicalTrials.gov

An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept Assay

NACompletedINTERVENTIONAL
Enrollment

685

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Treatment Resistant DepressionGeneralized Anxiety Disorder
Interventions
DEVICE

Genecept Assay

Genetic test which analyzes seven pharmacodynamic and three pharmacokinetic genes important in psychiatric disorders

Trial Locations (1)

18914

Genomind, LLC, Chalfont

Sponsors

Lead Sponsor

Genomind, LLC
All Listed Sponsors
lead

Genomind, LLC

INDUSTRY